文献速递心血管USMR

左心室舒张功能与整体纤维化负荷的关系:对心衰风险分层的意义

Relation of Left Ventricular Diastolic Function to Global Fibrosis Burden: Implications for Heart Failure Risk Stratification.
PubMed 文献 · JACC Cardiovasc Imaging · 2023-03-08

本研究纳入549例在30天内完成超声心动图和心脏磁共振(CMR)的患者,评估超声左室舒张功能与CMR整体纤维化负荷的关联,以及纤维化在舒张功能分级基础上对全因死亡和心衰住院的增量预测价值。结果显示舒张功能障碍分级越高,替代性纤维化和ECV越高;CMR纤维化负荷可为超声舒张功能评估提供增量预后信息。

要点

  • 超声舒张功能障碍分级II-III级与CMR替代性纤维化和ECV升高相关。
  • CMR整体纤维化负荷在超声舒张功能分级基础上提高复合终点预测能力。
  • CMR纤维化负荷对心衰住院预测也有显著增量价值。

核心结论

  • 舒张功能障碍分级越高,CMR检出的替代性纤维化和ECV越高。
  • CMR确定的纤维化负荷在超声评估左室舒张功能基础上提供增量预后信息。

研究设计与样本

  • 研究纳入549例在30天内完成全面超声心动图和CMR的患者。
  • 超声心动图评估左室舒张功能,CMR测定左室容积、质量、射血分数、替代性纤维化和细胞外容积分数(ECV)。
  • 参考标准为全因死亡和心衰住院复合终点。

关键影像表现/征象

  • 舒张功能正常者142例,其余为舒张功能障碍I-III级,另有18例(3.3%)结果不确定。

诊断标准与关键数值

  • 舒张功能障碍患者事件率高于舒张功能正常者(33.4% vs 15.5%,P < 0.001)。
  • 包含舒张功能II和III级的模型预测复合终点C-statistic为0.71(95% CI: 0.67-0.76),加入整体纤维化负荷后升至0.74(95% CI: 0.70-0.78;P = 0.02)。
  • 舒张功能II和III级竞争风险模型预测心衰住院C-statistic为0.78(95% CI: 0.74-0.83),加入整体纤维化负荷后升至0.80(95% CI: 0.76-0.85;P = 0.03)。

临床应用与阅片要点

  • 超声报告舒张功能障碍II-III级时,可提示CMR评估纤维化负荷以进一步风险分层。
  • CMR报告可关注替代性纤维化和ECV,辅助心衰风险预测。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Left ventricular (LV) diastolic function is primarily assessed by means of echocardiography, which has limited utility in detecting fibrosis. Cardiac magnetic resonance (CMR) readily detects and quantifies fibrosis.

OBJECTIVES: In this study, the authors sought to determine the association of LV diastolic function by echocardiography with CMR-determined global fibrosis burden and the incremental value of fibrosis with diastolic function grade in prediction of total mortality and heart failure hospitalizations.

METHODS: A total of 549 patients underwent comprehensive echocardiography and CMR within 30 days. Echocardiography was used to assess LV diastolic function, and CMR was used to determine LV volumes, mass, ejection fraction, replacement fibrosis, and percentage extracellular volume fraction (ECV).

RESULTS: Normal diastolic function was present in 142 patients; the rest had diastolic dysfunction grades I to III, except for 18 (3.3%) with indeterminate results. The event rate was higher in patients with diastolic dysfunction compared with patients with normal diastolic function (33.4% vs 15.5; P < 0.001). The model including LV diastolic function grades II and III predicted composite outcome (C-statistic: 0.71; 95% CI: 0.67-0.76), which increased by adding global fibrosis burden (C-statistic: 0.74, 95% CI: 0.70-0.78; P = 0.02). For heart failure hospitalizations, the competing risk model with LV diastolic function grades II and III was good (C-statistic: 0.78; 95% CI: 0.74-0.83) and increased significantly with the addition of global fibrosis burden (C-statistic: 0.80; 95% CI: 0.76-0.85; P = 0.03).

CONCLUSIONS: Higher grades of diastolic dysfunction are seen in patients with replacement fibrosis and increased ECV. Fibrosis burden as determined with the use of CMR provides incremental prognostic information to echocardiographic evaluation of LV diastolic function.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Lewandowski, Yang, Nguyen, et al. Relation of Left Ventricular Diastolic Function to Global Fibrosis Burden: Implications for Heart Failure Risk Stratification. JACC Cardiovasc Imaging. 2023. PMID: 37038874. doi:10.1016/j.jcmg.2022.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。